Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.
(2003) In The Lancet 362(9397). p.8-1691
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/119874
- author
- Olsson, Bertil LU
- organization
- publishing date
- 2003
- type
- Contribution to journal
- publication status
- published
- subject
- in
- The Lancet
- volume
- 362
- issue
- 9397
- pages
- 8 - 1691
- publisher
- Elsevier
- external identifiers
-
- scopus:0345414673
- ISSN
- 1474-547X
- DOI
- 10.1016/S0140-6736(03)14841-6
- language
- English
- LU publication?
- yes
- id
- 5642efce-287b-470e-8f2d-58d46a12261f (old id 119874)
- alternative location
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14643116&dopt=Abstract
- date added to LUP
- 2016-04-01 11:47:46
- date last changed
- 2022-04-28 20:00:55
@article{5642efce-287b-470e-8f2d-58d46a12261f,
author = {{Olsson, Bertil}},
issn = {{1474-547X}},
language = {{eng}},
number = {{9397}},
pages = {{8--1691}},
publisher = {{Elsevier}},
series = {{The Lancet}},
title = {{Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.}},
url = {{http://dx.doi.org/10.1016/S0140-6736(03)14841-6}},
doi = {{10.1016/S0140-6736(03)14841-6}},
volume = {{362}},
year = {{2003}},
}